The Effect of Aerobika Device and Acapella Device on Rehospitalisation and Pulmonary Functions in Patients with Chronic Obstructive Pulmonary Disease-A Systematic Review
Introduction: Controlling and preventing symptoms of exacerbations, shortness of breath, cough and mucus in the lungs are important goals of Chronic Obstructive Pulmonary Disease (COPD) treatment. Oscillating Positive Expiratory Pressure (OPEP) devices have been shown to improve clinical results...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-07-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/18124/58926_CE[Ra1]_F(IS)_PF1(SP_IS_OM)_PN_(KM).pdf |
Summary: | Introduction: Controlling and preventing symptoms of
exacerbations, shortness of breath, cough and mucus in the lungs
are important goals of Chronic Obstructive Pulmonary Disease
(COPD) treatment. Oscillating Positive Expiratory Pressure
(OPEP) devices have been shown to improve clinical results. The
conservation of energy and oxygen, as well as, the prevention of
lung infections and reducing rehospitalisation may be facilitated
by clearing the lungs. There are several airway clearance devices,
that can be used to help clear excessive sputum.
Aim: To identify the effect of aerobika device versus acapella
device on rehospitalisation and lung functions in COPD
patients.
Materials and Methods: This systematic review was conducted
in the Department of Physiotherapy at Acharya Vinoba Bhave
Rural Hospital, Sawangi, Wardha, Maharashtra, India. The
duration of the study was three months, from march 2022 to
june 2022. Five databases (PubMed, scopus, web of science,
google scholar) were searched from 2012 to 2022. Inclusion
criteria consisted of studies on the effect of aerobika device
and acapella device on rehospitalisation and lung functions
only in COPD patients. Data extraction included baseline
features, treatment intervention, training frequency, supervision
level, breathlessness, acute exacerbation, and outcomes. High
quality experimental trials and comparative studies were chosen
for the study.
Results: A total of 20 articles were extracted; five were utilised
for the purpose of writing the review, emphasising the effect of
aerobika device versus acapella device on rehospitalisation and
lung functions in COPD patients. Studies had showed inconsistent
results on the effect of aerobika device versus acapella device on
rehospitalisation and lung functions in COPD patients.
Conclusion: Rehospitalisation, readmission and length of
the stay can be reduced by using both, aerobika and acapella
devices. Both devices are effective in improving lung function in
COPD patients. |
---|---|
ISSN: | 2249-782X 0973-709X |